ArticleBMC cancer2011

Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group.

Claudio Sorio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.